New method allows controlled release of drugs; could help develop targeted treatments

Published on January 25, 2013 at 5:55 AM · No Comments

Researchers have discovered a method that allows for the controlled release of an active agent on the basis of a magnetic nanovehicle. The research, conducted as part of the National Research Programme "Smart Materials" (NRP 62), opens up new possibilities for the development of targeted treatments, which are more efficient and trigger fewer side effects.

Certain drugs are toxic by nature. For example, anti-cancer drugs developed to kill diseased cells also harm healthy ones. To limit the side effects of chemotherapy, it would be a great step forward if it were possible to release a drug only in the affected area of the body. In the context of the National Research Programme "Smart Materials" (NRP 62) - a cooperation between the SNSF and the Commission for Technology and Innovation (CTI) - researchers of ETH Lausanne, the Adolphe Merkle Institute and the University Hospital of Geneva have discovered a method that might represent an important step towards the development of an intelligent drug of this kind. By combining their expert knowledge in the areas of material sciences, biological nanomaterials and medicine, they were able to prove the feasibility of using a nanovehicle to transport drugs and release them in a controlled manner.

This nanocontainer is a liposome, which takes the shape of a vesicle. It has a diameter of 100 to 200 nanometers and is 100 times smaller than a human cell. The membrane of the vesicle is composed of phospholipids and the inside of the vesicle offers room for the drug. On the surface of the liposome, specific molecules help to target malignant cells and to hide the nanocontainer from the immune system, which might otherwise consider it a foreign entity and seek to destroy it. Now the researchers only needed to discover a mechanism to open up the membrane at will.

Nano effect
This is exactly what the researchers succeeded in doing (*). How they did it? By integrating into the liposome membrane superparamagnetic iron oxide nanoparticles (SPION), which only become magnetic in the presence of an external magnetic field. Once they are in the field, the SPION heat up. The heat makes the membrane permeable and the drug is released. Researchers proved the feasibility of such a nanovehicle by releasing in a controlled manner a coloured substance contained in the liposomes. "We can really talk of nanomedicine in this context because, by exploiting superparamagnetism, we are exploiting a quantum effect which only exists at the level of nanoparticles," explains Heinrich Hofmann of the Powder Technology Laboratory of EPFL. SPION are also an excellent contrast agent in magnetic resonance imaging (MRI). A simple MRI shows the location of the SPION and allows for the release of the drug once it has reached the targeted spot.

Read in | English | Español | Français | Deutsch | Português | Italiano | 日本語 | 한국어 | 简体中文 | 繁體中文 | Nederlands | Русский | Svenska | Polski
Comments
The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News-Medical.Net.
Post a new comment
Post